Han, Yiqun
Wu, Yun
Xu, Hangcheng
Wang, Jiayu http://orcid.org/0000-0003-1967-389X
Xu, Binghe http://orcid.org/0000-0002-0234-2747
Funding for this research was provided by:
China Anti-Cancer Association- Scientific Research Foundation of Anti-HER2 Targets Therapy (CORP-239)
Article History
Received: 18 October 2021
Accepted: 3 January 2022
First Online: 18 January 2022
Declarations
:
: The authors declare that they have no conflict of interest.